000 | 01134 a2200325 4500 | ||
---|---|---|---|
005 | 20250516223948.0 | ||
264 | 0 | _c20150330 | |
008 | 201503s 0 0 eng d | ||
022 | _a1744-8301 | ||
024 | 7 |
_a10.2217/fon.14.84 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAndrews, Miles C | |
245 | 0 | 0 |
_aEvolving role of tumor antigens for future melanoma therapies. _h[electronic resource] |
260 |
_bFuture oncology (London, England) _cJun 2014 |
||
300 |
_a1457-68 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 | _aAdaptive Immunity |
650 | 0 | 4 |
_aAntigens, Neoplasm _ximmunology |
650 | 0 | 4 | _aCancer Vaccines |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunomodulation |
650 | 0 | 4 | _aImmunotherapy, Adoptive |
650 | 0 | 4 |
_aMelanoma _ximmunology |
650 | 0 | 4 |
_aTumor Escape _ximmunology |
700 | 1 | _aWoods, Katherine | |
700 | 1 | _aCebon, Jonathan | |
700 | 1 | _aBehren, Andreas | |
773 | 0 |
_tFuture oncology (London, England) _gvol. 10 _gno. 8 _gp. 1457-68 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2217/fon.14.84 _zAvailable from publisher's website |
999 |
_c24033932 _d24033932 |